A Tennessee woman has filed C-Qur mesh lawsuit against Atrium Medical Corporation, alleging the company failed to warn her against the potential complications their device was associated with.

The C-Qur lawsuit alleges that due to the defective nature of the hernia mesh product, it had to be removed soon after implantation and ultimately compounded the claimant’s medical condition.

Plaintiff Jeretha C. opted to file this C-Qur lawsuit after discovering numerous other patients who may have experienced similar hernia mesh complications and is having her claim join a growing multidistrict litigation (MDL).

According to the C-Qur lawsuit, Jeretha had been prescribed the hernia mesh device for typical treatment purposes and had no reason to be wary of serious device complications.

Before the device was implanted, Jeretha’s physician had been relying on the marketing materials presented by Atrium, which she says described the C-Qur hernia mesh as a safe and effective option for her condition. The Atrium C-Qur hernia mesh product contains an omega 3 fatty acid coating which causes the body to respond with swelling, according to Jeretha’s complaint.

The inflammation is supposed to encourage tissue growth around the mesh, to help settle it. The inflammation is supposed to gradually dissipate and to help with recovery from the hernia mesh surgery. With these statements in mind, the C-Qur mesh was implanted on Oct. 16, 2009, but Jeretha says it had to be removed not long after due to serious device complications.

Even though the omega 3 fatty acid is supposed to induce swelling in the surrounding muscle, Jeretha claims this treatment mechanism can sometimes cause the patient’s issues to compound. When the swelling does not dissipate, it can allegedly lead to infection and cause the patient to experience pain from everyday activities.

Overview of Hernia Mesh Complications

When an infection develops in the hernia mesh area, it can lead to the formation of highly organized bacterial colonies called a biofilm. Biofilms are highly resistant to antibiotics, which makes removal of the hernia mesh necessary to resolve the infection.

Given the risk of this complication, Jeretha had to have the C-Qur mesh product removed on Aug. 4, 2010, with her physician citing pain and organ perforation as the reasons.

Patients who are at risk for developing hernia mesh infection may experience fever and other flu-like symptoms with other patients reporting dental problems. Early signs of hernia mesh infection are lack of healing on the surgical site and warmth emitting from the area, both of which indicate improper recovery.

Jeretha’s C-Qur mesh lawsuit is joining MDL No. 2753, where it will stand alongside other claims alleging similar injuries. By joining an MDL, Jeretha’s claim will be streamlined through the litigation process and will avoid potential problems like conflicting rulings from different judges.

At all times relevant, Jeretha and her physician were relying on the claims made by Atrium Medical Corporation and could not reasonably discover the risk of hernia mesh complications. Jeretha states she would not have agreed to use the C-Qur mesh product if she had known the risks of hernia mesh complications.

This C-Qur Mesh Lawsuit is Case No. 1:18-cv-00099, in the U.S. District Court of New Hampshire.